Drug
Metformin
Metformin: highest development phase Post-Market, developed by Aurobindo, Bristol-Myers Squibb, Dr. Reddy's and others. 6 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Aurobindo, Bristol-Myers Squibb, Dr. Reddy's
Trials
| Drug | Phase | Indication |
|---|---|---|
| metformin NCT00657943 | Post-Market | Type 2 Diabetes |
| Metformin XR NCT00778622 | Post-Market | Type 2 Diabetes Mellitus |
| METFORMIN HYDROCHLORIDE | Approved | |
| METFORMIN HYDROCHLORIDE | Approved | |
| Metformin NCT01160068 | Phase 1 | Healthy |
| Metformin HCL 500 mg Extended-Release Tablets, Geneva PTC NCT00882882 | Phase 1 | Type II Diabetes |
Latest
Follow Metformin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.